Concepedia

Luiza Coimbra Scalabrini

LC

Statistics

Publications

2

Citations

52

H-Index

2

Active since

2019

Affiliations

Institute of Biomedical Technologies(Current)

Beth Israel Deaconess Medical Center

Harvard University

National Research Council

Universidade de São Paulo

Luiza Coimbra Scalabrini is an author at Institute of Biomedical Technologies specializing in tumor biology, cell biology, and cancer biology.

Top concepts

Publications per year

2019–2020

2

Publications

2

Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer

Sandro Mascena Gomes-Filho, Edmilson Ozorio dos Santos, Ester Risério Matos Bertoldi et al. · Cellular Oncology · 2020 · 41 citations · Full text

, , +11

IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target

Tatiana Carneiro-Lobo, Luiza Coimbra Scalabrini, Leila da Silva Magalhães et al. · Lung Cancer · 2019 · 11 citations · Full text

, , +10

Rows per page

1–2 of 2